Global Respiratory Diagnostics Market to Reach US$ 14.7 Billion by 2032, Bolstered by Increasing Prevalence of Respiratory Diseases

September 26, 2022 | Healthcare

The latest report by IMARC Group, titled “Respiratory Diagnostics Market Report by Product and Service Type (Instruments and Services, Assays and Reagents, Services and Software), Test Type (Mechanical Tests, Obstructive Sleep Apnoea (OSA) Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, and Others), End-User (Hospitals, Clinics, Reference and Clinical Laboratories, and Others), and Region 2024-2032,” finds that the global respiratory diagnostics market size reached US$ 8.0 Billion in 2023. Respiratory diagnostics refer to the clinical examination of lung functioning and related procedures. It includes several mechanical, imaging, and molecular diagnostic tests for detecting chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, asthma, and pulmonary fibrosis. It also uses procedures such as capillary blood gas (CBG), sniff nasal inspiratory pressure (SNIP), spirometry, oximetry, transcutaneous CO2 monitoring, chest X-ray, and computed tomography (CT) scan. In some samples, sleep studies are also executed to diagnose and evaluate the presence of sleep apnea and nocturnal hypoventilation. As a result, respiratory diagnostic tests are widely conducted across healthcare sectors, clinical laboratories, and physician offices.

Global Respiratory Diagnostics Market Trends:

The market is primarily driven by the increasing prevalence of respiratory diseases. In addition, the increasing number of smokers and consumption of alcohol, sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung, mouth, and throat cancer. This, coupled with several technological innovations in the healthcare industry and respiratory diagnostic testing, including the utilization of artificial intelligence (AI) and the Internet of Things (IoT) for the diagnosis of COPD and outpatient management, represent another growth-inducing factor. Apart from this, the escalating demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers is providing a positive thrust to the market growth. Additionally, numerous initiatives taken by government and non-governmental organizations (NGOs) to make quality healthcare facilities accessible to all are also propelling the market growth. Other factors including rapid urbanization, the rising geriatric population and the increasing pollution levels across the globe are impelling the market growth. Looking forward, IMARC Group expects the market value to reach US$ 14.7 Billion by 2032, exhibiting a CAGR of 6.8% during the forecast period (2024-2032).

Market Summary:

  • Based on the product and service type, the market has been classified into instruments and services, assays and reagents, and services and software.
  • On the basis of the test type, the market has been divided into mechanical tests, obstructive sleep apnoea (OSA) diagnostic tests, imaging tests, traditional diagnostic tests, molecular diagnostic tests and others.
  • Based on the disease, the market has been segmented into tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), lung cancer and others.
  • On the basis of the end user, the market has been divided into hospitals, clinics, reference and clinical laboratories and others.
  • Region-wise, the market has been divided into North America, Europe, Asia Pacific, Middle East and Africa, Latin America.
  • The competitive landscape of the industry has also been examined in the report, with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M Company, Bio-Rad Laboratories, SDI Diagnostics and COSMED Srl.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product and Service Type, Test Type, Disease, End-User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Respiratory Diagnostics Market to Reach US$ 14.7 Billion by 2032, Bolstered by Increasing Prevalence of Respiratory Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More